Organisation
Hepatology
Division
The labo of Hepatology studies pathophysiology and treatment of liver and pancreas diseases and metabolism.
Current researchers
1 - 10 of 15 results
- Schalk Van der Merwe (Responsible)
- Isabelle Adant (Member)
- David Cassiman (Member)
- Rita Furtado Feio De Azevedo (Member)
- Hannelie Korf (Member)
- Wim Laleman (Member)
- Louis Libbrecht (Member)
- Frederik Nevens (Member)
- Lukas Van Melkebeke (Member)
- Marc Van de Casteele (Member)
Projects
1 - 10 of 50
- Unravelling aberrant host-microbiota interactions underlying intestinal epithelial barrier failure in cirrhosisFrom7 Feb 2024 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Harnessing single-cell and spatial transcriptomics to uncover novel insights into the pathological events that trigger the progression of acute-on-chronic liver failureFrom1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- Harnessing Single-Cell and Spatial Transcriptomics to Uncover Novel Insights into Intestinal Barrier Breach in CirrhosisFrom1 Oct 2023 → TodayFunding: Fund Recuperation Fiscal Exemption, BOF - projects
- Exploring the molecular mechanisms underlying bacterial translocation in cirrhosisFrom29 Sep 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Harnessing single-cell and spatial transcriptomics to uncover novel insights into the pathological events that trigger the progression of acute-on-chronic liver failureFrom1 Sep 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Validation and implementation of a prognostic biomarker of early graft failure after liver transplantation (GlycoTransplantTest)From1 Oct 2022 → TodayFunding: FWO Applied Biomedical Research (TBM)
- Model-informed precision dosing of tacrolimus in solid organ transplant recipientsFrom27 Jul 2022 → TodayFunding: FWO Strategic Basic Research Grant
- Design of robotic catheter and endoscopic systems for cancer treatmentFrom16 Feb 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Stratifying risk and individualizing care for patients with clinically significant portal hypertension (CSPH)From7 Oct 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Metabolic rewiring in SORDD polyneuropathy: unraveling a polyol pathway disorderFrom1 Oct 2021 → TodayFunding: FWO fellowships
Publications
21 - 30 of 1343
- Kras mutation reflects the different cholangiocytes pheno- and genotype in intrahepatic cholangiocarcinoma(2012)
Authors: Komuta Mina, Chris Verslype, Sara Vander Borght, Vincent Vandecaveye, Werner Van Steenbergen, Wim Laleman, Jacques Pirenne, Raymond Aerts, Frederik Nevens, Baki Topal, et al.
Pages: 444 - Belgian experience with direct acting antivirals in people who inject drugs(2017)
Authors: Rob Bielen, Christophe Moreno, Hans Van Vlierberghe, Stefan Bourgeois, Jean-Pierre Mulkay, Thomas Vanwolleghem, Wim Verlinden, Christian Brixko, Jochen Decaestecker, Chantal De Galocsy, et al.
Pages: 214 - 220 - Early-TIPS improves survival in high-risk variceal bleeders. Results of a Multicenter Variceal Bleeding Observational Study(2016)
Authors: Virginia Hernandez-Gea, Bogdan Procopet, Alvaro Giraldez, Lucio Amitrano, Candid Villanueva, Dominique Thabut, Luis Ibanez Samaniego, Gilberto Silva-Junior, Agustin Albillos, Joan Genesca, et al.
Pages: 47 - Factors predicting survival in patients with high-risk acute variceal bleeding treated with pre-emptive (Early)-TIPS(2019)
Authors: Debora Angrisani, Virginia Hernandez-Gea, Bogdan Procopet, Karel Caca, Alvaro Giraldez-Gallego, Lucio Amitrano, Maria Anna Guardascione, Candid Villanueva, Edilmar Alvarado, Dominique Thabut, et al.
Pages: E17 - E18 - SPIRIT-PRO Extension explanation and elaboration: guidelines for inclusion of patient-reported outcomes in protocols of clinical trials(2021)
Authors: Thomas Morel
- A more intensive regimen of albumin dyalisis improves survival in patients with acute on chronic liver failure, results from an individual-patient data meta-analysis(2016)
Authors: LI Samaniego, C Olmedo, M Pavesi, J Torner, MV Catalina, T Hassanein, U Heemann, Frederik Nevens, F Larsen, R Jalan, et al.
Pages: S272 - S273 - Comparable efficacy-safety and better renal function with everolimus and reduced-exposure tacrolimus versus standard-exposure tacrolimus in liver transplant recipients: H2304 and H2307 pooled analysis(2019)
Authors: G Levy, SG Lee, L-B Jeng, AS Soin, W-C Lee, P De Simone, Frederik Nevens, K-S Suh, L Fischer, DJ Joo, et al.
Pages: 36 - 36 - Impact of Acute-on-Chronic Liver Failure on response to treatment with terlipressin and albumin in patients with type 1 hepatorenal syndrome(2017)
Authors: S Piano, HH Schmidt, X Ariza, A Amoros, A Romano, E Sola, AL Gerbes, M Bernardi, C Alessandria, J Trebicka, et al.
Pages: S572 - S572 - ENDURANCE-4: Efficacy and Safety of ABT-493/ABT-530 Treatment in Patients with Chronic HCV Genotype 4, 5, or 6 Infection(2016)
Authors: Tarik Asselah, Christophe Hezode, Neddie Zadeikis, Magdy Elkhashab, Massimo Colombo, Rui T Marinho, Kosh Agarwal, Frederik Nevens, Ran Liu, Teresa Ng, et al.
Pages: 63A - 63A - "Splanchnische veneuze trombose;"(2010)
Authors: Frederik Nevens
Pages: 100 - 103